Valuation : Teva Pharmaceutical Industries Limited

Market Cap 42.46B 0 36.59B 34.31B 31.32B 59B 4,058B 59.19B 407B 159B 2,049B 159B 156B 6,793B P/E 2026 *
48.9x
P/E 2027 * 20x
Enterprise Value 54.34B 0 46.83B 43.9B 40.08B 75.5B 5,194B 75.74B 521B 203B 2,622B 204B 200B 8,693B EV / Sales 2026 *
3.28x
EV / Sales 2027 * 2.95x
Free-Float
88.59%
Yield 2026 *
-
Yield 2027 * -
1 day-1.61%
1 week+0.09%
Current month+1.47%
1 month+15.08%
3 months+12.59%
6 months+3.96%
Current year+9.32%
1 week 10,980
Extreme 10980
11,440
1 month 10,180
Extreme 10180
11,440
Current year 8,860
Extreme 8860
11,440
1 year 6,082
Extreme 6082
11,440
3 years 3,250
Extreme 3250
11,440
5 years 2,383
Extreme 2383
11,440
10 years 2,175
Extreme 2175
19,900
Manager TitleAgeSince
Chief Executive Officer 57 01/01/2023
Director of Finance/CFO 53 22/12/2019
Chief Operating Officer 52 03/06/2024
Director TitleAgeSince
Director/Board Member 69 01/01/2009
Chairman 78 06/02/2017
Director/Board Member 65 01/09/2015
Change 5-day change 1-year change 3-year change Capi.($)
-1.61%+0.09% - - 42.46B
-0.13%-6.44%+60.47%+112.05% 1,047B
+0.85%-0.81%+52.77%+63.15% 646B
-1.03%-3.58%+22.87%+73.29% 451B
-1.46%-4.50%+37.43%+38.41% 355B
-0.72%-2.89%+21.86%+36.79% 291B
-1.19%-2.21%+1.35%+12.29% 252B
-1.05%-1.57%+51.40%+68.55% 234B
+0.08%-1.78%-17.64%-54.29% 203B
-2.14%-0.30%+29.42%+89.10% 181B
Average -0.85%-2.68%+28.88%+48.82% 406.59B
Weighted average by Cap. -0.50%-3.46%+38.66%+65.51%

Financials

2026 *2027 *
Net sales 16.58B 0 14.29B 13.4B 12.23B 23.04B 1,585B 23.11B 159B 62.02B 800B 62.26B 60.9B 2,653B 17.3B 0 14.91B 13.98B 12.76B 24.04B 1,654B 24.12B 166B 64.72B 835B 64.97B 63.56B 2,768B
Net income 1.44B 0 1.24B 1.16B 1.06B 2B 138B 2.01B 13.81B 5.39B 69.52B 5.41B 5.29B 231B 2.69B 0 2.32B 2.17B 1.98B 3.74B 257B 3.75B 25.77B 10.05B 130B 10.09B 9.87B 430B
Net Debt 11.88B 0 10.23B 9.6B 8.76B 16.5B 1,135B 16.55B 114B 44.42B 573B 44.59B 43.62B 1,900B 8.61B 0 7.42B 6.96B 6.35B 11.96B 823B 12B 82.54B 32.2B 415B 32.33B 31.63B 1,378B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
28/08/26 ILA 11,030.00 -1.61% 1,399,391
27/08/26 ILA 11,210.00 +0.45% 812,651
26/08/26 ILA 11,160.00 -0.45% 740,192
25/08/26 ILA 11,210.00 +1.08% 1,192,310
24/08/26 ILA 11,090.00 +0.64% 727,266
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
36.44USD
Average target price
41.40USD
Spread / Average Target
+13.61%

Quarterly revenue - Rate of surprise